These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15970791)

  • 21. HER2 polymorphism and breast cancer risk in Portugal.
    Pinto D; Vasconcelos A; Costa S; Pereira D; Rodrigues H; Lopes C; Medeiros R
    Eur J Cancer Prev; 2004 Jun; 13(3):177-81. PubMed ID: 15167216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of HER2 codon 655 polymorphism with ovarian cancer.
    Watrowski R; Castillo-Tong DC; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Tumour Biol; 2016 Jun; 37(6):7239-44. PubMed ID: 26666819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of Ile655Val polymorphism on trastuzumab-induced cardiotoxicity in early-stage HER2 positive breast cancer.
    Vazdar L; Gabrić ID; Kruljac I; Pintarić H; Šeparović R; Kirigin Biloš LS; Pavlović M; Tečić Vuger A; Štefanović M
    Sci Rep; 2021 Jul; 11(1):14395. PubMed ID: 34257352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
    Stanton SE; Ward MM; Christos P; Sanford R; Lam C; Cobham MV; Donovan D; Scheff RJ; Cigler T; Moore A; Vahdat LT; Lane ME; Chuang E
    BMC Cancer; 2015 Apr; 15():267. PubMed ID: 25885598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
    Wang L; Habuchi T; Takahashi T; Kamoto T; Zuo T; Mitsumori K; Tsuchiya N; Sato K; Ogawa O; Kato T
    Int J Cancer; 2002 Feb; 97(6):787-90. PubMed ID: 11857355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between the Arg72Pro Genotypes in the TP53 Gene and Ile655Val in the HER2 Gene and the Risk of Developing Breast Cancer in the Population of Amapá, Northern Brazil.
    Cardoso YMN; Resque RL; Yoshio D; B Miranda AR; Secco M; Do N Rodrigues AS
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):157-162. PubMed ID: 36708564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
    Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity.
    Beauclair S; Formento P; Fischel JL; Lescaut W; Largillier R; Chamorey E; Hofman P; Ferrero JM; Pagès G; Milano G
    Ann Oncol; 2007 Aug; 18(8):1335-41. PubMed ID: 17693647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.
    Chen W; Yang H; Tang WR; Feng SJ; Wei YL
    Asian Pac J Cancer Prev; 2014; 15(22):9643-7. PubMed ID: 25520082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab.
    Lemieux J; Diorio C; Côté MA; Provencher L; Barabé F; Jacob S; St-Pierre C; Demers E; Tremblay-Lemay R; Nadeau-Larochelle C; Michaud A; Laflamme C
    Anticancer Res; 2013 Jun; 33(6):2569-76. PubMed ID: 23749910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.
    Riaz SK; Rashid MM; Kayani MA; Arshad Malik MF
    Arch Iran Med; 2016 Jun; 19(6):430-8. PubMed ID: 27293060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HER2 codon 655 polymorphism is associated with advanced uterine cervical carcinoma.
    Kruszyna Ł; Lianeri M; Roszak A; Jagodziński PP
    Clin Biochem; 2010 Apr; 43(6):545-8. PubMed ID: 20026098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer.
    Kuraoka K; Matsumura S; Hamai Y; Nakachi K; Imai K; Matsusaki K; Oue N; Ito R; Nakayama H; Yasui W
    Int J Cancer; 2003 Nov; 107(4):593-6. PubMed ID: 14520697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Her2
    Krishna BM; Chaudhary S; Panda AK; Mishra DR; Mishra SK
    Sci Rep; 2018 May; 8(1):7427. PubMed ID: 29743533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of serum tumor necrosis factor-alpha and its combination with HER-2 codon 655 polymorphism in the diagnosis and prognosis of breast cancer.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Int J Biol Markers; 2010; 25(3):126-35. PubMed ID: 20872355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of HER2 genotypes as molecular markers on breast cancer outcome.
    Mutluhan H; Akbas E; Erdogan NE; Soylemez F; Senli MS; Polat A; Helvaci I; Seyrek E
    DNA Cell Biol; 2008 Oct; 27(10):575-9. PubMed ID: 18721072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors.
    Furrer D; Lemieux J; Côté MA; Provencher L; Laflamme C; Barabé F; Jacob S; Michaud A; Diorio C
    Breast; 2016 Dec; 30():191-196. PubMed ID: 27788409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.